Disease | myocardial infarction |
Symptom | |diabetes |
Sentences | 128 |
PubMedID- 23270530 | Showed that acute myocardial infarction (mi) patients with igt or diabetes exhibited higher levels of high-sensitivity c-reactive protein and interleukin-6 levels compared with acute mi patients with normal glucose tolerance or well-controlled diabetes, indicating that glycol metabolism in acute mi is associated with acute stress and inflammation. |
PubMedID- 22763393 | In particular, further studies focusing on the risk of acute myocardial infarction in patients with diabetes treated with intravitreal vascular endothelial growth factor inhibitors are warranted. |
PubMedID- 25860211 | Most prevalent were hypertension, coronary artery disease, diabetes, and previous history of myocardial infarction (table 1). |
PubMedID- 24529823 | Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. |
PubMedID- 23593140 | The full models were further adjusted for bmi, smoking (current, former, and never), alcohol consumption (<12, ≥12 drinks in the past year), systolic blood pressure, blood pressure lowing medication, total and hdl cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, use of qt-prolonging medications, and creatinine-based egfr. |
PubMedID- 21736547 | Furthermore, meta-analysis of seven long-term studies suggested that acarbose reduced the risk of myocardial infarction for patients with type 2 diabetes . |
PubMedID- 26209521 | Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. |
PubMedID- 22211855 | No differences were found in symptoms of myocardial infarction between women with and without diabetes or between men with and without diabetes. |
PubMedID- 22858312 | Association of manganese superoxide dismutase and glutathione s-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. |
PubMedID- 24374422 | Conclusions: both overall pss and cvd subgroup-specific pss achieved good balance on measured covariates when assessing the relative association of diabetes monotherapy with nonfatal myocardial infarction. |
PubMedID- 23915139 | Achieving early glycemic control in patients with newly diagnosed diabetes reduces the risk of microvascular complications, myocardial infarction, and all-cause mortality . |
PubMedID- 25790544 | Materials and methods: a total of 100 type 2 diabetes patients with myocardial infarction and 50 normal individuals were selected for this analysis. |
PubMedID- 23960432 | We are intrigued this study conducted as a student project for 3 months, with strict criteria excluding patients with systolic blood pressure >170 mmhg and <100 mmhg, diabetes mellitus, past history of myocardial infarction, renal impairment, hepatic impairment, cerebrovascular event, moderate to severe heart failure, bradycardia, second to third degree heart block, arrhythmias, history of drug intake namely diltiazem, verapamil, beta blockers, simvastatin, digoxin, amiodarone, phenytoin etc., could still manage to recruit a sizeable number of patients for such a short period. |
PubMedID- 23635324 | In the cardiovascular inflammation reduction trial (cirt) low dose methotrexate (target dose 20 mg/week) is tested for reduction of major cvd events among post-myocardial infarction patients with diabetes or metabolic syndrome. |
PubMedID- 25193670 | Effects of baseline coronary occlusion and diabetes mellitus in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. |
PubMedID- 25078899 | Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction. |
PubMedID- 21562320 | Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the rosiglitazone evaluated for cardiac outcomes and regulation of glycemia in diabetes (record) study. |
PubMedID- 25579653 | Age and education, previous and current smoking, systolic blood pressure, hdl cholesterol, type 2 diabetes, family history of myocardial infarction, total cholesterol and use of statins. |
PubMedID- 20465096 | The risk of myocardial infarction in patients with type 2 diabetes is 3-5 times higher than in non-diabetics. |
PubMedID- 22815296 | Over the last decades, the prevalence of diabetes in patients with a myocardial infarction (mi) has increased significantly (1–3). |
PubMedID- 25411597 | These results might be clinically meaningful if the levels could be maintained long term, as it has been reported that a reduction of hba1c by 1% has been associated with a 21% reduction in the relative risk of death, 37% reduction in risk of microvascular complications and 14% reduction in risk of myocardial infarction15 in patients with type 2 diabetes mellitus. |
PubMedID- 22665216 | Exclusion criteria were type 1 diabetes, history of stroke, myocardial infarction within six months, other clinically important cardiac diseases, arrhythmias, significant nephropathy, kidney or liver transplant, renal or congestive heart failure, carotid artery stenosis (over 50% by medical history and magnetic resonance angiography), and any neurologic or systemic disorders (aside from peripheral neuropathy). |
PubMedID- 26445676 | In addition, patients who survive aki have worse long-term outcomes than patients with diabetes mellitus and survivors of an st-elevation myocardial infarction . |
PubMedID- 26379783 | The exclusion criteria were: type 2 diabetes mellitus, history of myocardial infarction, clinically significant valvular heart disease, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, smoking (>20 cigarettes/day), polytherapy, obstructive sleep apnea. |
PubMedID- 26151031 | Ros are generally regarded as a final common pathway for cell death and are elicited by all manner of tissue insults, such as diabetes-induced complications, ischemia associated with myocardial infarction or stroke, inflammatory stimuli such as endotoxin, and many anticancer drugs. |
PubMedID- 22247906 | Patients with type 2 diabetes without a history of myocardial infarction are regarded to have the same risk of a coronary event as patients without diabetes who have a history of myocardial infarction 6. |
PubMedID- 21447495 | Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. |
PubMedID- 22498999 | Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus. |